Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0SG9W
|
|||
| Drug Name |
PMID30185082-Compound-64
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
COGNITION THERAPEUTICS, INC. CATALANO, Susan, M. RISHTON, Gilbert IZZO, Nicholas, J
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H22F3NO2
|
|||
| Canonical SMILES |
CC(CCC1=CC(=C(C=C1)O)OC)NCC2=CC=C(C=C2)C(F)(F)F
|
|||
| InChI |
1S/C19H22F3NO2/c1-13(3-4-14-7-10-17(24)18(11-14)25-2)23-12-15-5-8-16(9-6-15)19(20,21)22/h5-11,13,23-24H,3-4,12H2,1-2H3
|
|||
| InChIKey |
JWMMMNZRBWMHKZ-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Opioid receptor sigma 1 (OPRS1) | Target Info | Ligand | [1] |
| Sigma intracellular receptor 2 (TMEM97) | Target Info | Ligand | [1] | |
| Target's Patent Info | Opioid receptor sigma 1 (OPRS1) | Target's Patent Info | [1] | |
| Sigma intracellular receptor 2 (TMEM97) | Target's Patent Info | [1] | ||
| WikiPathways | miR-targeted genes in squamous cell - TarBase | |||
| miR-targeted genes in lymphocytes - TarBase | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The sigma-2 (-2) receptor: a review of recent patent applications: 2013-2018.Expert Opin Ther Pat. 2018 Sep;28(9):655-663. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.